发明授权
- 专利标题： Neuromedin and FN-38 peptides for treating psychiatric diseases
- 专利标题（中）： 神经介肽和FN-38肽用于精神疾病
-
申请号： US12524903申请日： 2008-02-04
-
公开(公告)号： US08309522B2公开(公告)日： 2012-11-13
- 发明人: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Paul McGonigle
- 申请人： Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Paul McGonigle
- 申请人地址： US CA San Diego
- 专利权人： Amylin Pharmaceuticals, LLC
- 当前专利权人： Amylin Pharmaceuticals, LLC
- 当前专利权人地址： US CA San Diego
- 代理机构： Amylin Pharmaceuticals, LLC
- 国际申请： PCT/US2008/001500 WO 20080204
- 国际公布： WO2008/097536 WO 20080814
- 主分类号： A61K38/00
- IPC分类号： A61K38/00
摘要：
Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.